Physcion 8-O-beta-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis | |
Wang, Qiang; Yan, Yi; Zhang, Jie; Guo, Peng; Xing, Yuqing; Wang, Yong; Qin, Fawei; Zeng, Qingyun | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY
![]() |
2018 | |
卷号 | 104页码:28-35 |
关键词 | PG ccRCC Apoptosis Glycolysis HK2 |
DOI | 10.1016/j.biopha.2018.05.013 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4582558 |
专题 | 山东大学 |
作者单位 | Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R Chin |
推荐引用方式 GB/T 7714 | Wang, Qiang,Yan, Yi,Zhang, Jie,et al. Physcion 8-O-beta-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,104:28-35. |
APA | Wang, Qiang.,Yan, Yi.,Zhang, Jie.,Guo, Peng.,Xing, Yuqing.,...&Zeng, Qingyun.(2018).Physcion 8-O-beta-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.BIOMEDICINE & PHARMACOTHERAPY,104,28-35. |
MLA | Wang, Qiang,et al."Physcion 8-O-beta-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis".BIOMEDICINE & PHARMACOTHERAPY 104(2018):28-35. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论